Cancer survivor fights to stop gene ownership

Images and Videos (2)

Court case probes validity of gene patent

abc.net.au
How can we best reward creators and those who benefit from their creations?

theconversation.edu.au

View all images/videos

From other news sites (5)

Cancer survivor fights to stop gene ownership

abc.net.au | 8:35 am Feb 20, 2012

A breast cancer survivor says she is challenging a patent claim on cancer genes because she does not want biotech companies to own human material. A landmark case challenging the ownership of breast and ovarian cancer genes has begun in the Federal Court…
IP, patents, copyright, you

theconversation.edu.au | 3:10 am Feb 20, 2012

The concept of protecting ideas and innovation by legal means dates back to antiquity. But in the age of the internet and multinational business models, many of the existing laws are under strain, their suitability and ultimate purpose called into question.
Bruce Arnold kicks off a new series on The Conversation looking at where we are, where we were and where we’re going with regards to patents, copyright, trademarks and IP.
It’s become a cliché that most Australians are part of an information society or information economy. In fact, we’re all part of an intellectual property society. Intellectual property (IP) affects what we consume and what we create. It also affects when we’re born and when we die, given modern medicine is founded on pharmaceuticals and devices that are encouraged by intellectual property law.
This article offers a snapshot, quick and irreverent, of what IP is, why it’s controversial, and the difference between some key terms.
In essence, IP law provides rights owners with the power to stop unauthorised copying. That power is for a finite period of years. At the end of the period (which can be as little as five years) the owners’ rights evaporate.

Read the full article at The Conversation.
Landmark cancer gene case in court

sbs.com.au | 12:56 pm Feb 20, 2012

A cancer survivor and a consumer organisation have taken two biotech companies to court over a patent related to a human gene linked to breast and ovarian cancers. On Monday, a Federal Court judge began hearing the landmark case brought by Brisbane woman…
Myriad Genetics’ Australian Cancer Gene Patents Go on Trial

businessweek.com | 2:28 pm Feb 20, 2012

Adds plaintiffs’ lawyer’s comment in 10th paragraph.) Feb. 20 (Bloomberg) -- Myriad Genetics Inc. and other biotechnology companies can’t monopolize disease treatment by patenting human genetic material, an Australian trial was told in the country’s first…
Myriad Genetics’ Australia Cancer Gene Patents Face Sydney Court Challenge

bloomberg.com | 4:22 am Feb 20, 2012

Euro Region Ministers Circle In on Greek Rescue